Antiviral API Process Development
It is well known that reliable and robust API process development is the foundation for delivering high-quality antiviral APIs. BOC Sciences works closely with our customers to identify and develop tailored processes for each project to meet your antiviral API program requirements while exceeding expectations in terms of quality, safety, efficiency and sustainability. Our years of experience in API development allow us to deliver robust and scalable results, while our expertise in emerging technologies allows us to solve the most complex chemical challenges. BOC Sciences' API process development team has fully equipped laboratories to handle the most complex API development challenges for antiviral drugs.
Our Capabilities
- Development of reliable and scalable routes, including process economic assessments, regulatory strategy establishment, and cost of goods reduction (COGS) studies
- Synthesis & process chemistry, and analytical method development
- Analytical method identification/validation, and preliminary stability analysis
- Process optimization and enhanced control
Figure 1. Process chemistry in antiviral research. (Yong-Li, Z; et al. 2016)
Expertise in API Process Development
Our strong expertise in antiviral APIs research enables us to increase process robustness, and therefore accelerate timelines to answer your needs. Our innovative technologies coupled with our strength in process chemistry, allows our teams to develop and implement novel generation processes to extend antiviral drug product lifecycles.
- A full range of process chemistry services, including proof of concept (POC), process development, quality by design (QbD), design of experiments (DOE) and critical material attributes (CMAs) research
- BOC Sciences' state-of-the-art facilities and team of experts are capable of supporting the most complex and challenging small-molecule antiviral APIs compounds
- At BOC Sciences, we combine scientific collaboration with years of proven track record in complex and hazardous chemistry to support your antiviral drug molecules from discovery to commercial launch
- Strong analytical services
Ensuring the quality and reliability of each method requires extensive analytical expertise. With a team of experienced analytical scientists and a full suit of specialized equipment, BOC Sciences has the ability to develop, test and validate analytical methods to support the robust release of final antiviral drug products.
- Technology innovation
Through our continuously updated technology and innovation program, we are able to explore innovative solutions to our customers' API development challenges. We identify technologies that bring the most value to our customers and continue to develop our capabilities in these areas to help them stay at the forefront of industry innovation.
Why Partner with BOC Sciences?
- We apply our years of proven expertise and experience in antiviral drug development to improve the success of your program
- Our continuously updated facilities support a range of antiviral drug analysis and manufacturing services
- BOC Sciences' experienced team of scientists and regulatory staffs are focused on working with our clients to deliver timely and high-quality small molecule antiviral drugs
- Our partnerships with leading experts in emerging technologies allow us to apply innovative solutions to your antiviral drug research programs
Reference
- Yong-Li, Z.; et al. Process Chemistry in Antiviral Research. Topics in Current Chemistry. 2016. 374: 77.
※ Please kindly note that our services are for research use only.
